loadpatents
name:-0.012943983078003
name:-0.011910915374756
name:-0.0062770843505859
Palmer; Brian Desmond Patent Filings

Palmer; Brian Desmond

Patent Applications and Registrations

Patent applications and USPTO patent grants for Palmer; Brian Desmond.The latest application filed is for "inhibitors of tryptophan dioxygenases (ido1 and tdo) and their use in therapy".

Company Profile
6.11.11
  • Palmer; Brian Desmond - Auckland NZ
  • Palmer; Brian Desmond - West Harbour NZ
  • Palmer; Brian Desmond - Waitakere City N/A NZ
  • Palmer; Brian Desmond - Waitakere NZ
  • Palmer, Brian Desmond - Glendene NZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
Grant 11,414,428 - Palmer , et al. August 16, 2
2022-08-16
INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY
App 20210145839 - Palmer; Brian Desmond ;   et al.
2021-05-20
Antibacterial compounds and uses thereof
Grant 10,981,891 - Upton , et al. April 20, 2
2021-04-20
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
Grant 10,888,567 - Palmer , et al. January 12, 2
2021-01-12
Antibacterial Compounds And Uses Thereof
App 20200039955 - Upton; Anna Marie ;   et al.
2020-02-06
Antibacterial compounds and uses thereof
Grant 10,508,097 - Upton , et al. Dec
2019-12-17
Antibacterial Compounds And Uses Thereof
App 20190071417 - Upton; Anna Marie ;   et al.
2019-03-07
Inhibitors of Tryptophan Dioxygenases (IDO1 and TDO) And Their Use In Therapy
App 20180244692 - Palmer; Brian Desmond ;   et al.
2018-08-30
INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY
App 20170224701 - Palmer; Brian Desmond ;   et al.
2017-08-10
Nitroimidazooxazines and their uses in anti-tubercular therapy
Grant 9,198,913 - Denny , et al. December 1, 2
2015-12-01
Nitroimidazooxazines And Their Uses In Anti-tubercular Therapy
App 20120028973 - Denny; William Alexander ;   et al.
2012-02-02
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
Grant 7,666,864 - Ding , et al. February 23, 2
2010-02-23
Bicyclic Nitroimidazole-substituted Phenyl Oxazolidinones
App 20090281088 - Ding; Charles Z. ;   et al.
2009-11-12
Imidazopyridine And Imidazopyrimidine Derivatives As Antibacterial Agents
App 20090275577 - Sciotti; Richard John ;   et al.
2009-11-05
Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents
Grant 7,563,788 - Sciotti , et al. July 21, 2
2009-07-21
Antibacterial agents
App 20070191394 - Sciotti; Richard John ;   et al.
2007-08-16
Inhibitors of checkpoint kinases (Wee1 and Chk1)
Grant 7,094,798 - Booth , et al. August 22, 2
2006-08-22
Inhibitors of checkpoint kinases (Wee1 and Chk1)
App 20050250836 - Booth, Richard John ;   et al.
2005-11-10
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 6,218,388 - Boschelli , et al. April 17, 2
2001-04-17
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 5,990,146 - Boschelli , et al. November 23, 1
1999-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed